Javascript must be enabled to continue!
ChREBP-Knockout Mice Show Sucrose Intolerance and Fructose Malabsorption
View through CrossRef
We have previously reported that 60% sucrose diet-fed ChREBP knockout mice (KO) showed body weight loss resulting in lethality. We aimed to elucidate whether sucrose and fructose metabolism are impaired in KO. Wild type mice (WT) and KO were fed a diet containing 30% sucrose with/without 0.08% miglitol, an α-glucosidase inhibitor, and these effects on phenotypes were tested. Furthermore, we compared metabolic changes of oral and peritoneal fructose injection. Thirty percent sucrose diet feeding did not affect phenotypes in KO. However, miglitol induced lethality in 30% sucrose-fed KO. Thirty percent sucrose plus miglitol diet-fed KO showed increased cecal contents, increased fecal lactate contents, increased growth of lactobacillales and Bifidobacterium and decreased growth of clostridium cluster XIVa. ChREBP gene deletion suppressed the mRNA levels of sucrose and fructose related genes. Next, oral fructose injection did not affect plasma glucose levels and liver fructose contents; however, intestinal sucrose and fructose related mRNA levels were increased only in WT. In contrast, peritoneal fructose injection increased plasma glucose levels in both mice; however, the hepatic fructose content in KO was much higher owing to decreased hepatic Khk mRNA expression. Taken together, KO showed sucrose intolerance and fructose malabsorption owing to decreased gene expression.
Title: ChREBP-Knockout Mice Show Sucrose Intolerance and Fructose Malabsorption
Description:
We have previously reported that 60% sucrose diet-fed ChREBP knockout mice (KO) showed body weight loss resulting in lethality.
We aimed to elucidate whether sucrose and fructose metabolism are impaired in KO.
Wild type mice (WT) and KO were fed a diet containing 30% sucrose with/without 0.
08% miglitol, an α-glucosidase inhibitor, and these effects on phenotypes were tested.
Furthermore, we compared metabolic changes of oral and peritoneal fructose injection.
Thirty percent sucrose diet feeding did not affect phenotypes in KO.
However, miglitol induced lethality in 30% sucrose-fed KO.
Thirty percent sucrose plus miglitol diet-fed KO showed increased cecal contents, increased fecal lactate contents, increased growth of lactobacillales and Bifidobacterium and decreased growth of clostridium cluster XIVa.
ChREBP gene deletion suppressed the mRNA levels of sucrose and fructose related genes.
Next, oral fructose injection did not affect plasma glucose levels and liver fructose contents; however, intestinal sucrose and fructose related mRNA levels were increased only in WT.
In contrast, peritoneal fructose injection increased plasma glucose levels in both mice; however, the hepatic fructose content in KO was much higher owing to decreased hepatic Khk mRNA expression.
Taken together, KO showed sucrose intolerance and fructose malabsorption owing to decreased gene expression.
Related Results
Role du fructose dans la physiopathologie du syndrome de l'intestin irritable
Role du fructose dans la physiopathologie du syndrome de l'intestin irritable
.La consommation journalière de fructose est en augmentation croissante, jusqu'à plus de 50g par jour aux Etats-Unis et en Europe de l'Ouest. Le fructose est de plus en plus incorp...
ChREBP deficiency aggravates diabetic sarcopenia by disrupting glucose signaling: a novel mouse model of muscle atrophy
ChREBP deficiency aggravates diabetic sarcopenia by disrupting glucose signaling: a novel mouse model of muscle atrophy
Diabetes is an increasingly prevalent global disease and is often accompanied by sarcopenia, particularly in older adults. While insulin resistance is a well-known contributor to m...
ChREBP Rather than SHP Regulates Hepatic VLDL Secretion
ChREBP Rather than SHP Regulates Hepatic VLDL Secretion
The regulation of hepatic very-low-density lipoprotein (VLDL) secretion plays an important role in the pathogenesis of dyslipidemia and fatty liver diseases. VLDL is controlled by ...
Abstract FR511: Sucrose elevates blood pressure in mice: a new metabolic model for human hypertension?
Abstract FR511: Sucrose elevates blood pressure in mice: a new metabolic model for human hypertension?
Introduction:
Sucrose is a disaccharide composed of glucose and fructose linked by an α-1,2-glycosidic bond. It is a major sweetener and the main ingredient in ...
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
While virtually absent in our diet a few hundred years ago, fructose has now become a major constituent of our modern diet. Our main sources of fructose are sucrose from beet or ca...
Gene variants of the SLC2A5 gene encoding GLUT5, the major fructose transporter, do not contribute to clinical presentation of acquired fructose malabsorption
Gene variants of the SLC2A5 gene encoding GLUT5, the major fructose transporter, do not contribute to clinical presentation of acquired fructose malabsorption
Abstract
Background
While role of
ALDOB-
related gene ...
Gene Variants of the SLC2A5 Gene Encoding GLUT5, the Major Fructose Transporter, Do Not Contribute to Clinical Presentation of Acquired Fructose Malabsorption.
Gene Variants of the SLC2A5 Gene Encoding GLUT5, the Major Fructose Transporter, Do Not Contribute to Clinical Presentation of Acquired Fructose Malabsorption.
Abstract
Background: While role of ALDOB-related gene variants for hereditary fructose intolerance is well established, contribution of gene variants for acquired fructose ...
Glucose-Sensing ChREBP Protein in the Pathogenesis of Diabetic Retinopathy
Glucose-Sensing ChREBP Protein in the Pathogenesis of Diabetic Retinopathy
AbstractGlucose-sensing ChREBP and MondoA are transcriptional factors involved in lipogenic, inflammatory, and insulin signaling pathways implicated in metabolic disorders; however...

